Management of patients with ventricular tachycardia in Europe: results of the European Heart Rhythm Association survey.
The purpose of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in the management of ventricular tachycardia (VT). The data are based on an electronic questionnaire sent to the members of the EHRA Research Network. Responses were received from 31 centres in 16 countries. The results of the survey show that the management of VT is in general in accordance with guidelines. Antiarrhythmic drugs are still frequently used for VT treatment. In patients at high risk of sudden cardiac death, an implantable cardioverter-defibrillator is routinely recommended, while the treatment options vary for patients with moderate or low risk. A discreet attitude is adopted for catheter ablation in high-risk patients as demonstrated by a relatively low rate of catheter ablation.
Department of Heart Disease, Haukeland University Hospital and Department of Clinical Science, University of Bergen, N-5021 Bergen, Norway jian.chen@med.uib.no.
Jian
J
Chen
Liverpool Heart and Chest Hospital, Thomas Drive, Liverpool L14 3PE, UK.
Derick M
DM
Todd
Division of Cardiology, University Hospital S. Maria della Misericordia, IRCAB Foundation Udine, Udine, Italy.
Alessandro
A
Proclemer
Department of Cardiology, Institution of Medical Science, Uppsala University, 75185 Uppsala, Sweden.
Elena
E
Sciaraffia
Department of Cardiology, I. Medizinische Klinik, Ludwig-Maximilians-Universität, Campus Großhadern, Marchioninistrasse 15, 81377 München, Germany.
Heidi L
HL
Estner
Aberdeen Royal Infirmary, Foresterhill, Aberdeen AB25 2ZN, UK.
Paul
P
Broadhurst
Department of Cardiology, Institution of Medical Science, Uppsala University, 75185 Uppsala, Sweden.
Carina
C
Blomström-Lundqvist
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D017115:Catheter Ablation / Q000706:statistics & numerical data*; D017147:Defibrillators, Implantable / Q000706:statistics & numerical data*; D005060:Europe / Q000453:epidemiology; D005260:Female; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D015995:Prevalence; D012307:Risk Factors; D017180:Tachycardia, Ventricular / Q000453:epidemiology* / Q000628:therapy*; D016896:Treatment Outcome
D000889:Anti-Arrhythmia Agents
Antiarrhythmic drugs; Catheter ablation; EHRA survey; EP Wire; Implantable cardioverter-defibrillator; Ventricular tachycardia